Clinical trial
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
NCT00225823 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00225823 |
|---|---|
| Title | Study In Adults And Adolescents With Seasonal Allergic Rhinitis. |
| Official title | A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multicentre Two Week Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis in Europe |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rhinitis, Allergic, Seasonal |
| Intervention type | Drug |
| Interventions | GW685698X |
| Enrollment | 288 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 26, 2005 |
| Last update posted | Sep 15, 2016 |
| Countries | Estonia, Latvia, Lithuania, Netherlands, Russia, Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: